Latest news for Allied Gaming (OTC:AGAEW) Stock

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

Allied Gaming & Entertainment Inc Warrants (09/08/2024)

Allied Gaming & Entertainment Inc

Over the past 24 hours, Wrapped Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WBTC</a>) price has fallen 3.12% to $66,131.00. This continues its negative trend over the past week where it has experienced a 1.0% loss, moving from $66,945.11 to its current price. 
The chart below compares the price movement and volatility for Wrapped Bitcoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1722351754_0.png" alt="price_chart" />
The trading volume for the coin has climbed 10.0% over the past week, moving opposite, directionally, with the overall circulating supply of the coin, which has decreased 0.35%. This brings the circulating supply to 154 thousand, which makes up an estimated 100.0% of its max supply of 154 thousand. According to our data, the current market cap ranking for WBTC is #14 at $10.22 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1722351754_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

Movers

Trading Ideas

$WBTC

Wrapped Bitcoin Decreases More Than 3% Within 24 hours

Avalanche's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/avax/usd">AVAX</a>) price has decreased 4.11% over the past 24 hours to $26.6, continuing its downward trend over the past week of -13.0%, moving from $30.49 to its current price. 
The chart below compares the price movement and volatility for Avalanche over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1722351745_0.png" alt="price_chart" />
The trading volume for the coin has fallen 45.0% over the past week which is opposite, directionally, with the overall circulating supply of the coin, which has increased 0.03%. This brings the circulating supply to 394.87 million, which makes up an estimated 54.84% of its max supply of 720.00 million. According to our data, the current market cap ranking for AVAX is #13 at $10.51 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1722351746_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$AVAX

Avalanche Down More Than 4% Within 24 hours

Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) users faced access issues and degraded performance with multiple Microsoft 365 services and features, according to its social network site <a target="_blank" href="https://x.com/MSFT365Status/status/1818267438435147865?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet" rel="noreferrer noopener">X post</a>.
Microsoft 365 users reported outage instances at 9:26 am&nbsp;Tuesday, Eastern Time (ET), as per <a target="_blank" href="https://downdetector.com/status/microsoft-365/?_gl=1&#x2A;rdait4&#x2A;_up&#x2A;MQ..&#x2A;_ga&#x2A;MTA1NjU4NzA2OS4xNzIyMzQ2ODQ0&#x2A;_ga_0PZM58H213&#x2A;MTcyMjM0Njg0My4xLjEuMTcyMjM0Njg2MS4wLjAuMA.." rel="noreferrer noopener">Downdetector</a>.
Close to 46% of the users reported issues with Outlook, 35% with the website, and 19% with the App, as per Downdetector.
<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39858714/crowdstrike-shares-trim-heavy-losses-as-microsoft-announces-resolution-of-global-te" rel="noreferrer noopener">In early July</a>, an unsuccessful update to CrowdStrike Holdings Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) Falcon platform caused significant disruptions in <a target="_blank" href="https://www.benzinga.com/news/24/07/39930356/crowdstrike-blames-error-with-test-software-for-taking-down-8-5m-windows-computers-globally-says-a-n" rel="noreferrer noopener">8.5 million</a> Microsoft systems, halting critical global services, including airports, ports, financial institutions, and hospitals.
The outage caused by CrowdStrike has had significant global implications. The CEO, George Kurtz, has been summoned by a<a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39897729/crowdstrike-ceo-george-kurtz-to-testify-before-congress-on-faulty-update-causing-global-disrupti" rel="noreferrer noopener"> U.S. congressional panel</a> to testify on the global tech outage.
Microsoft services were up and running as per the company&#8217;s <a target="_blank" href="https://admin.microsoft.com/servicestatus." rel="noreferrer noopener">latest post</a>.
Price Action: MSFT shares traded lower by 0.44% at $424.85 at the last check on Tuesday.
Photo courtesy: Unsplash

News

Tech

Media

CRWD

MSFT

Microsoft 365 Outage: Users Report Issues with Outlook, Website, and App

Textron Aviation Expands Service Offerings With New Repair Process For Cessna Citation 560XL Main Landing Gear; Collaboration With Able Aerospace Services Allows Significant Repairs Without Full Replacement, Offering Cost-Effective Option For Customers

Whales with a lot of money to spend have taken a noticeably bearish stance on Lululemon Athletica.
Looking at options history for Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $197,300 and 5, calls, for a total amount of $702,797.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $340.0 for Lululemon Athletica, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Lululemon Athletica stands at 434.29, with a total volume reaching 545.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Lululemon Athletica, situated within the strike price corridor from $200.0 to $340.0, throughout the last 30 days.
<h3>Lululemon Athletica 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722351709_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$9.9</td>
<td>$9.3</td>
<td>$9.65</td>
<td>$330.00</td>
<td>$434.2K</td>
<td style="text-align: right;">377</td>
<td style="text-align: right;">450</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$11.0</td>
<td>$10.4</td>
<td>$11.0</td>
<td>$340.00</td>
<td>$110.0K</td>
<td style="text-align: right;">182</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$17.25</td>
<td>$15.85</td>
<td>$16.95</td>
<td>$250.00</td>
<td>$67.8K</td>
<td style="text-align: right;">479</td>
<td style="text-align: right;">40</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$17.6</td>
<td>$16.2</td>
<td>$16.85</td>
<td>$250.00</td>
<td>$67.4K</td>
<td style="text-align: right;">479</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$69.95</td>
<td>$63.85</td>
<td>$65.25</td>
<td>$270.00</td>
<td>$65.2K</td>
<td style="text-align: right;">20</td>
<td style="text-align: right;">10</td>
</tr>
</tbody>
</table>

<h3>About Lululemon Athletica</h3>
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 700 company-owned stores in about 20 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
After a thorough review of the options trading surrounding Lululemon Athletica, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Lululemon Athletica's Current Market Status</h3>
<ul>
<li>Trading volume stands at 380,424, with LULU's price down by -1.21%, positioned at $255.9.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Professional Analyst Ratings for Lululemon Athletica</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $299.6.
<ul>
<li>Reflecting concerns, an analyst from Citigroup lowers its rating to Neutral with a new price target of $300.</li>
<li>Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Lululemon Athletica, targeting a price of $338. </li>
<li>An analyst from TD Cowen has decided to maintain their Buy rating on Lululemon Athletica, which currently sits at a price target of $420. </li>
<li>Maintaining their stance, an analyst from Jefferies continues to hold a Underperform rating for Lululemon Athletica, targeting a price of $220. </li>
<li>Reflecting concerns, an analyst from Jefferies lowers its rating to Underperform with a new price target of $220.</li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Lululemon Athletica with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

LULU

Unpacking the Latest Options Trading Trends in Lululemon Athletica

Deep-pocketed investors have adopted a bullish approach towards Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LRCX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for Lam Research. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 12 are puts, totaling $788,230, and 2 are calls, amounting to $235,055.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $810.0 to $1180.0 for Lam Research during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Lam Research's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Lam Research's substantial trades, within a strike price spectrum from $810.0 to $1180.0 over the preceding 30 days.
<h3>Lam Research Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722351705_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$70.6</td>
<td>$68.95</td>
<td>$68.95</td>
<td>$880.00</td>
<td>$199.9K</td>
<td style="text-align: right;">68</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$48.2</td>
<td>$47.7</td>
<td>$47.7</td>
<td>$880.00</td>
<td>$162.1K</td>
<td style="text-align: right;">95</td>
<td style="text-align: right;">4</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$47.95</td>
<td>$47.25</td>
<td>$47.25</td>
<td>$880.00</td>
<td>$113.4K</td>
<td style="text-align: right;">95</td>
<td style="text-align: right;">62</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/02/24</td>
<td>$22.0</td>
<td>$21.95</td>
<td>$22.0</td>
<td>$870.00</td>
<td>$103.4K</td>
<td style="text-align: right;">70</td>
<td style="text-align: right;">61</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/02/24</td>
<td>$111.3</td>
<td>$102.8</td>
<td>$107.9</td>
<td>$1000.00</td>
<td>$64.7K</td>
<td style="text-align: right;">81</td>
<td style="text-align: right;">6</td>
</tr>
</tbody>
</table>

<h3>About Lam Research</h3>
Lam Research is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segments of deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear cut second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
Having examined the options trading patterns of Lam Research, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Lam Research</h3>
<ul>
<li>Currently trading with a volume of 164,457, the LRCX's price is down by -0.64%, now at $886.61. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 1 days.</li>
</ul>
<h3>What Analysts Are Saying About Lam Research</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $1200.0.
<ul>
<li>Consistent in their evaluation, an analyst from Cantor Fitzgerald keeps a Neutral rating on Lam Research with a target price of $1200. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Lam Research, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

LRCX

Unpacking the Latest Options Trading Trends in Lam Research

Whales with a lot of money to spend have taken a noticeably bullish stance on Viking Therapeutics.
Looking at options history for Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $110,037 and 13, calls, for a total amount of $918,292.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $35.0 and $70.0 for Viking Therapeutics, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale activity within a strike price range from $35.0 to $70.0 in the last 30 days. 
<h3>Viking Therapeutics Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722351700_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$28.2</td>
<td>$28.0</td>
<td>$28.0</td>
<td>$35.00</td>
<td>$140.0K</td>
<td>1.8K</td>
<td style="text-align: right;">151</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$28.3</td>
<td>$27.3</td>
<td>$27.8</td>
<td>$35.00</td>
<td>$139.0K</td>
<td>1.8K</td>
<td style="text-align: right;">101</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$28.0</td>
<td>$27.4</td>
<td>$27.78</td>
<td>$35.00</td>
<td>$138.9K</td>
<td>1.8K</td>
<td style="text-align: right;">251</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$28.0</td>
<td>$27.4</td>
<td>$27.77</td>
<td>$35.00</td>
<td>$138.8K</td>
<td>1.8K</td>
<td style="text-align: right;">201</td>
</tr>
<tr>
<td>VKTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$17.0</td>
<td>$15.8</td>
<td>$16.43</td>
<td>$55.00</td>
<td>$82.1K</td>
<td>288</td>
<td style="text-align: right;">50</td>
</tr>
</tbody>
</table>

<h3>About Viking Therapeutics</h3>
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
<h3>Viking Therapeutics's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,690,111, the VKTX's price is down by -4.0%, now at $58.8. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 85 days.</li>
</ul>
<h3>Expert Opinions on Viking Therapeutics</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $104.0.
<ul>
<li>An analyst from Raymond James has decided to maintain their Strong Buy rating on Viking Therapeutics, which currently sits at a price target of $118. </li>
<li>An analyst from HC Wainwright &amp; Co. has revised its rating downward to Buy, adjusting the price target to $90. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

VKTX

Looking At Viking Therapeutics's Recent Unusual Options Activity

Revealing a significant insider sell on July 29, Joseph Simon, Chief Financial Officer at Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>), as per the latest SEC filing.
What Happened: Simon's decision to sell 6,723 shares of Moelis was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001596967/000095017024087449//Archives/edgar/data/1596967/000095017024087449/0000950170-24-087449-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total value of the sale is $430,272.
Monitoring the market, Moelis's shares down by 0.0% at $67.39 during Tuesday's morning.
<h3>Delving into Moelis's Background</h3>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Understanding the Numbers: Moelis's Finances</h3>
Revenue Growth: Moelis displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 47.1%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: With a low gross margin of 25.21%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Moelis's EPS reflects a decline, falling below the industry average with a current EPS of 0.18.
</li>
</ul>
Debt Management: Moelis's debt-to-equity ratio is below the industry average. With a ratio of 0.59, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Navigating Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 449.27, Moelis's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 5.03, Moelis's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 855.43, Moelis demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001596967">Check Out The Full List Of Moelis's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Joseph Simon Takes Money Off The Table, Sells $430K In Moelis Stock

Disclosed on July 29, Strategic Value Partners LLC, 10% Owner at CBL &amp; Associates (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBL#NYSE">CBL</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: LLC's recent move involves selling 19,710 shares of CBL &amp; Associates. This information is documented in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000910612/000106299324014145//Archives/edgar/data/910612/000106299324014145/0001062993-24-014145-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total value is $509,416.
The latest market snapshot at Tuesday morning reveals CBL &amp; Associates shares down by 0.0%, trading at $25.95.
<h3>Delving into CBL &amp; Associates's Background</h3>
CBL &amp; Associates Properties Inc is a U.S.-based real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
<h3>Breaking Down CBL &amp; Associates's Financial Performance</h3>
Revenue Challenges: CBL &amp; Associates's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -5.31%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: With a low gross margin of 66.67%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): CBL &amp; Associates's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of -0.01.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 5.74, caution is advised due to increased financial risk.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: CBL &amp; Associates's current Price to Earnings (P/E) ratio of 259.5 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.54, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): CBL &amp; Associates's EV/EBITDA ratio at 6.62 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000910612">Check Out The Full List Of CBL &amp; Associates's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

10% Owner Of CBL & Associates Sold $509K In Stock

Making a noteworthy insider sell on July 29, SVP Excelsior Management LLC, 10% Owner at CBL &amp; Associates (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBL#NYSE">CBL</a>), is reported in the latest SEC filing.
What Happened: LLC opted to sell 19,710 shares of CBL &amp; Associates, according to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000910612/000106299324014146//Archives/edgar/data/910612/000106299324014146/0001062993-24-014146-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The transaction's total worth stands at $509,416.
Tracking the Tuesday's morning session, CBL &amp; Associates shares are trading at $25.95, showing a down of 0.0%.
<h3>About CBL &amp; Associates</h3>
CBL &amp; Associates Properties Inc is a U.S.-based real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
<h3>Financial Milestones: CBL &amp; Associates's Journey</h3>
Negative Revenue Trend: Examining CBL &amp; Associates's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -5.31% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 66.67%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): CBL &amp; Associates's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of -0.01.
</li>
</ul>
Debt Management: CBL &amp; Associates's debt-to-equity ratio stands notably higher than the industry average, reaching 5.74. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: CBL &amp; Associates's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 259.5.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.54, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a lower-than-industry-average EV/EBITDA ratio of 6.62, CBL &amp; Associates presents a potential value opportunity, as investors are paying less for each unit of EBITDA.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Transaction Codes To Focus On</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000910612">Check Out The Full List Of CBL &amp; Associates's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Unloading: SVP Excelsior Management LLC Sells $509K Worth Of CBL & Associates Shares

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Northern Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Northern Trust, presenting an average target of $88.0, a high estimate of $93.00, and a low estimate of $84.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 4.61%. 
<img src="https://www.benzinga.com/files/images/story/2024/1722351681_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Northern Trust by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$93.00</td>
<td>$97.00</td>
</tr>
<tr>
<td>Gerard Cassidy</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$84.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$85.00</td>
<td>$92.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Northern Trust. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Northern Trust compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Northern Trust's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Northern Trust's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/NTRS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Northern Trust analyst ratings.</a>
<h2>Get to Know Northern Trust Better</h2>
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of Dec. 31, 2023, Northern Trust had assets under custody or administration of $15.4 trillion and assets under management of $1.4 trillion.
<h3>Financial Insights: Northern Trust</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Northern Trust's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 118.24% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Northern Trust's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 24.61%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Northern Trust's ROE stands out, surpassing industry averages. With an impressive ROE of 7.69%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Northern Trust's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.57%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.16.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

NTRS

Unveiling 4 Analyst Insights On Northern Trust

It was reported on July 30, that Lindsey S Caplan, Chief Accounting Officer at CBRE Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) executed a significant insider sell, according to an SEC filing.
What Happened: After conducting a thorough analysis, Caplan sold 2,000 shares of CBRE Group. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001138118/000122520824007617//Archives/edgar/data/1138118/000122520824007617/0001225208-24-007617-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total transaction value is $219,746.
During Tuesday's morning session, CBRE Group shares up by 0.44%, currently priced at $111.03.
<h3>Get to Know CBRE Group Better</h3>
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. Additionally, CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.
<h3>CBRE Group: Delving into Financials</h3>
Positive Revenue Trend: Examining CBRE Group's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 8.69% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 19.04%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 0.42, CBRE Group showcases strong earnings per share.
</li>
</ul>
Debt Management: CBRE Group's debt-to-equity ratio is below the industry average. With a ratio of 0.78, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 37.22 is lower than the industry average, implying a discounted valuation for CBRE Group's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.03, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 21.7, CBRE Group's EV/EBITDA ratio reflects a below-par valuation compared to industry averages signalling undervaluation
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001138118">Check Out The Full List Of CBRE Group's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CBRE

CBRE Group Chief Accounting Officer Sold $219K In Company Stock

Solana's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) price has decreased 3.67% over the past 24 hours to $180.75. This is contrary to the coins performance over the past week where it has experienced an up-trend of 1.0%, moving from $178.12 to its current price.
The chart below compares the price movement and volatility for Solana over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1722351676_0.png" alt="price_chart" />
The trading volume for the coin has decreased 1.0% over the past week, while the overall circulating supply of the coin has increased 0.18% to over 464.82 million. The current market cap ranking for SOL is #4 at $84.06 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1722351676_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$SOL

Solana Decreases More Than 3% Within 24 hours

Making a noteworthy insider sell on July 30, PADRAIG MCDONNELL, President and CEO at Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>), is reported in the latest SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001090872/000112760224021131//Archives/edgar/data/1090872/000112760224021131/0001127602-24-021131-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday showed that MCDONNELL sold 1,958 shares of Agilent Technologies. The total transaction amounted to $274,120. 
Monitoring the market, Agilent Technologies's shares down by 0.0% at $137.38 during Tuesday's morning.
<h3>Unveiling the Story Behind Agilent Technologies</h3>
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
<h3>Key Indicators: Agilent Technologies's Financial Health</h3>
Revenue Challenges: Agilent Technologies's revenue growth over 3 months faced difficulties. As of 30 April, 2024, the company experienced a decline of approximately -8.39%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 54.42%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Agilent Technologies's EPS reflects a decline, falling below the industry average with a current EPS of 1.05.
</li>
</ul>
Debt Management: Agilent Technologies's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.41.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: Agilent Technologies's P/E ratio of 32.55 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 6.14 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 24.46, Agilent Technologies presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001090872">Check Out The Full List Of Agilent Technologies's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

President and CEO Of Agilent Technologies Sold $274K In Stock

In a new SEC filing on July 29, it was revealed that Macino, Board Member at CorVel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVL#NASDAQ">CRVL</a>), executed a significant exercise of company stock options.
What Happened: Macino, Board Member at CorVel, exercised stock options for 3,000 shares of CRVL stock. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000874866/000142623224000004//Archives/edgar/data/874866/000142623224000004/0001426232-24-000004-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The exercise price of the options was $40.57 per share.
The Tuesday morning market activity shows CorVel shares down by 0.0%, trading at $307.82. This implies a total value of $801,750 for Macino's 3,000 shares.
<h3>Get to Know CorVel Better</h3>
CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.
<h3>CorVel: Financial Performance Dissected</h3>
Revenue Growth: CorVel displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 11.75%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 20.94%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): CorVel's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 1.13.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.13.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 69.96 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 6.71 is above industry norms, reflecting an elevated valuation for CorVel's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 42.93, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000874866">Check Out The Full List Of CorVel's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRVL

Jean Macino At CorVel Executes Options Exercise, Realizing $801K

Ratings for Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $41.4, with a high estimate of $45.00 and a low estimate of $39.00. Witnessing a positive shift, the current average has risen by 25.45% from the previous average price target of $33.00.
<img src="https://www.benzinga.com/files/images/story/2024/1722351666_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The perception of Criteo by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Nowak</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Shyam Patil</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Tom White</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Criteo. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Criteo compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Criteo's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Criteo's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CRTO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Criteo analyst ratings.</a>
<h2>Unveiling the Story Behind Criteo</h2>
Headquartered in Paris, Criteo is one of the leading ad-tech companies in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
<h3>Financial Milestones: Criteo's Journey</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Criteo's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 1.13%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: Criteo's net margin excels beyond industry benchmarks, reaching 1.61%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Criteo's ROE excels beyond industry benchmarks, reaching 0.68%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Criteo's ROA excels beyond industry benchmarks, reaching 0.31%. This signifies efficient management of assets and strong financial health.
Debt Management: Criteo's debt-to-equity ratio is below the industry average. With a ratio of 0.11, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRTO

Analyst Expectations For Criteo's Future

Joseph R Holmes, VP &amp; Chief Accounting Officer at Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), reported a large exercise of company stock options on July 29, according to a new SEC filing.
What Happened: Holmes, VP &amp; Chief Accounting Officer at Thermo Fisher Scientific, exercised stock options for 860 shares of TMO stock. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000097745/000112760224021121//Archives/edgar/data/97745/000112760224021121/0001127602-24-021121-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The exercise price of the options was $230.07 per share.
Thermo Fisher Scientific shares are currently trading down by 0.0%, with a current price of $604.12 as of Tuesday morning. This brings the total value of Holmes's 860 shares to $324,027.
<h3>All You Need to Know About Thermo Fisher Scientific</h3>
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
<h3>Financial Milestones: Thermo Fisher Scientific's Journey</h3>
Revenue Growth: Over the 3 months period, Thermo Fisher Scientific showcased positive performance, achieving a revenue growth rate of 1.89% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 42.07%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 4.05, Thermo Fisher Scientific showcases strong earnings per share.
</li>
</ul>
Debt Management: Thermo Fisher Scientific's debt-to-equity ratio is below the industry average. With a ratio of 0.75, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Valuation Analysis:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 37.48 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 5.5 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 22.09, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.
</li>
</ul>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000097745">Check Out The Full List Of Thermo Fisher Scientific's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Joseph R Holmes At Thermo Fisher Scientific Decides to Exercises Options Worth $324K

In a new SEC filing on July 29, it was revealed that Zdimal, VP &amp; Chief Financial Officer at Carlisle Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSL#NYSE">CSL</a>), executed a significant exercise of company stock options.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000790051/000079005124000168//Archives/edgar/data/790051/000079005124000168/0000790051-24-000168-index.htm">U.S. Securities and Exchange Commission</a> on Monday revealed that Zdimal, VP &amp; Chief Financial Officer at Carlisle Companies in the Industrials sector, exercised stock options for 14,245 shares of CSL stock. The exercise price of the options was $129.71 per share.
Carlisle Companies shares are currently trading down by 0.0%, with a current price of $426.15 as of Tuesday morning. This brings the total value of Zdimal's 14,245 shares to $4,222,734.
<h3>Unveiling the Story Behind Carlisle Companies</h3>
Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.
<h3>Key Indicators: Carlisle Companies's Financial Health</h3>
Revenue Growth: Over the 3 months period, Carlisle Companies showcased positive performance, achieving a revenue growth rate of 10.99% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: With a high gross margin of 39.22%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): Carlisle Companies's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 15.03.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.76, Carlisle Companies adopts a prudent financial strategy, indicating a balanced approach to debt management.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 24.14, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 4.21 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio of 14.91 trails industry averages, indicating a potential disparity in market valuation that could be advantageous for investors.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>A Closer Look at Important Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000790051">Check Out The Full List Of Carlisle Companies's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

At Carlisle Companies, Kevin P Zdimal Chooses To Exercise Options, Resulting In $4.22M

Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $64.83, a high estimate of $70.00, and a low estimate of $59.00. This current average reflects an increase of 1.3% from the previous average price target of $64.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1722351650_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Wells Fargo among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$68.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>James Fotheringham</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$59.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>John Pancari</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$67.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$61.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Ken Usdin</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$64.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>John Pancari</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$69.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Wells Fargo. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Wells Fargo compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Wells Fargo's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Wells Fargo's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WFC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Wells Fargo analyst ratings.</a>
<h2>Delving into Wells Fargo's Background</h2>
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
<h3>Unraveling the Financial Story of Wells Fargo</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Challenges: Wells Fargo's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.83%. This indicates a decrease in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Wells Fargo's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 22.43% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Wells Fargo's ROE stands out, surpassing industry averages. With an impressive ROE of 2.88%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.24%, the company showcases effective utilization of assets.
Debt Management: Wells Fargo's debt-to-equity ratio surpasses industry norms, standing at 1.86. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Navigating 6 Analyst Ratings For Wells Fargo

In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) in relation to its major competitors in the Semiconductors &amp; Semiconductor Equipment industry. By closely examining key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and highlight company's performance in the industry.
<h3>Advanced Micro Devices Background</h3>
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications, among others. AMD's traditional strength was in central processing units, CPUs, and graphics processing units, or GPUs, used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array, or FPGA, leader Xilinx to diversify its business and augment its opportunities in key end markets such as the data center and automotive.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Advanced Micro Devices Inc</td>
<td>202.54</td>
<td>4.02</td>
<td>10</td>
<td>0.22%</td>
<td>$0.9</td>
<td>$2.56</td>
<td>2.24%</td>
</tr>
<tr>
<td>NVIDIA Corp</td>
<td>65.30</td>
<td>55.86</td>
<td>34.88</td>
<td>32.31%</td>
<td>$17.75</td>
<td>$20.41</td>
<td>262.12%</td>
</tr>
<tr>
<td>Broadcom Inc</td>
<td>64.72</td>
<td>9.99</td>
<td>15.84</td>
<td>3.02%</td>
<td>$5.58</td>
<td>$7.78</td>
<td>42.99%</td>
</tr>
<tr>
<td>Qualcomm Inc</td>
<td>23.82</td>
<td>8.15</td>
<td>5.53</td>
<td>9.79%</td>
<td>$3.08</td>
<td>$5.28</td>
<td>1.23%</td>
</tr>
<tr>
<td>Texas Instruments Inc</td>
<td>34.99</td>
<td>10.71</td>
<td>11.50</td>
<td>6.59%</td>
<td>$1.76</td>
<td>$2.21</td>
<td>-15.65%</td>
</tr>
<tr>
<td>ARM Holdings PLC</td>
<td>487.72</td>
<td>27.99</td>
<td>45.70</td>
<td>4.35%</td>
<td>$0.06</td>
<td>$0.89</td>
<td>46.6%</td>
</tr>
<tr>
<td>Intel Corp</td>
<td>31.78</td>
<td>1.24</td>
<td>2.36</td>
<td>-0.36%</td>
<td>$2.09</td>
<td>$5.22</td>
<td>8.61%</td>
</tr>
<tr>
<td>Analog Devices Inc</td>
<td>53.13</td>
<td>3.20</td>
<td>10.87</td>
<td>0.85%</td>
<td>$0.93</td>
<td>$1.18</td>
<td>-33.83%</td>
</tr>
<tr>
<td>Microchip Technology Inc</td>
<td>25.28</td>
<td>7.09</td>
<td>6.31</td>
<td>2.25%</td>
<td>$0.47</td>
<td>$0.79</td>
<td>-40.62%</td>
</tr>
<tr>
<td>Monolithic Power Systems Inc</td>
<td>98.60</td>
<td>19.05</td>
<td>22.10</td>
<td>4.45%</td>
<td>$0.1</td>
<td>$0.25</td>
<td>1.51%</td>
</tr>
<tr>
<td>ON Semiconductor Corp</td>
<td>17.83</td>
<td>4.02</td>
<td>4.42</td>
<td>5.7%</td>
<td>$0.71</td>
<td>$0.85</td>
<td>-4.95%</td>
</tr>
<tr>
<td>GLOBALFOUNDRIES Inc</td>
<td>31.98</td>
<td>2.52</td>
<td>4.04</td>
<td>1.19%</td>
<td>$0.54</td>
<td>$0.39</td>
<td>-15.86%</td>
</tr>
<tr>
<td>First Solar Inc</td>
<td>23.10</td>
<td>3.42</td>
<td>6.64</td>
<td>3.48%</td>
<td>$0.36</td>
<td>$0.35</td>
<td>44.83%</td>
</tr>
<tr>
<td>ASE Technology Holding Co Ltd</td>
<td>20.46</td>
<td>2.33</td>
<td>1.21</td>
<td>2.62%</td>
<td>$26.08</td>
<td>$23.07</td>
<td>2.91%</td>
</tr>
<tr>
<td>United Microelectronics Corp</td>
<td>11.29</td>
<td>1.64</td>
<td>2.74</td>
<td>2.9%</td>
<td>$24.0</td>
<td>$16.9</td>
<td>0.78%</td>
</tr>
<tr>
<td>Skyworks Solutions Inc</td>
<td>22.11</td>
<td>2.96</td>
<td>4.16</td>
<td>2.91%</td>
<td>$0.31</td>
<td>$0.42</td>
<td>-9.29%</td>
</tr>
<tr>
<td>Universal Display Corp</td>
<td>49.62</td>
<td>7.29</td>
<td>17.79</td>
<td>3.86%</td>
<td>$0.07</td>
<td>$0.13</td>
<td>26.67%</td>
</tr>
<tr>
<td>Lattice Semiconductor Corp</td>
<td>40.41</td>
<td>10.82</td>
<td>12.18</td>
<td>2.15%</td>
<td>$0.03</td>
<td>$0.1</td>
<td>-23.6%</td>
</tr>
<tr>
<td>MACOM Technology Solutions Holdings Inc</td>
<td>111.84</td>
<td>6.86</td>
<td>11.28</td>
<td>1.45%</td>
<td>$0.04</td>
<td>$0.1</td>
<td>6.98%</td>
</tr>
<tr>
<td>Cirrus Logic Inc</td>
<td>26.73</td>
<td>3.85</td>
<td>4.10</td>
<td>2.48%</td>
<td>$0.07</td>
<td>$0.19</td>
<td>-0.27%</td>
</tr>
<tr>
<td>Average</td>
<td>65.3</td>
<td>9.95</td>
<td>11.77</td>
<td>4.84%</td>
<td>$4.42</td>
<td>$4.55</td>
<td>15.85%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>After a detailed analysis of Advanced Micro Devices, the following trends become apparent: 
<ul>
<li>
The Price to Earnings ratio of 202.54 for this company is 3.1x above the industry average, indicating a premium valuation associated with the stock.
</li>
<li>
Considering a Price to Book ratio of 4.02, which is well below the industry average by 0.4x, the stock may be undervalued based on its book value compared to its peers.
</li>
<li>
Based on its sales performance, the stock could be deemed undervalued with a Price to Sales ratio of 10.0, which is 0.85x the industry average.
</li>
<li>
The company has a lower Return on Equity (ROE) of 0.22%, which is 4.62% below the industry average. This indicates potential inefficiency in utilizing equity to generate profits, which could be attributed to various factors.
</li>
<li>
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $900 Million is 0.2x below the industry average, suggesting potential lower profitability or financial challenges.
</li>
<li>
The company has lower gross profit of $2.56 Billion, which indicates 0.56x below the industry average. This potentially indicates lower revenue after accounting for production costs.
</li>
<li>
The company's revenue growth of 2.24% is significantly below the industry average of 15.85%. This suggests a potential struggle in generating increased sales volume.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722351641_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio indicates the proportion of debt and equity used by a company to finance its assets and operations.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
When comparing Advanced Micro Devices with its top 4 peers based on the Debt-to-Equity ratio, the following insights can be observed:
<ul>
<li>
Advanced Micro Devices exhibits a stronger financial position compared to its top 4 peers in the sector, as indicated by its lower debt-to-equity ratio of 0.05.
</li>
<li>
This suggests that the company has a more favorable balance between debt and equity, which can be seen as a positive aspect for investors.
</li>
</ul>
<h3>Key Takeaways</h3>
For Advanced Micro Devices, the PE ratio is high compared to peers, indicating potentially overvalued stock. The PB and PS ratios are low, suggesting undervaluation relative to industry competitors. In terms of ROE, EBITDA, gross profit, and revenue growth, Advanced Micro Devices lags behind its peers, indicating weaker financial performance and growth prospects within the Semiconductors &amp; Semiconductor Equipment industry.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Allied Gaming

News

Latest news for Allied Gaming (OTC:AGAEW) Stock